Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel

By Nishiya Y.   Hagihara K.   Kurihara A.   Okudaira N.   Farid N.A.   Okazaki O.   Ikeda T.  

Xenobiotica, Vol. 39, Iss. 11, 2009-11 ,pp. : 836-843

Informa Healthcare

Access to resources Recommend Favorite

Polymerase Chain Reaction–Single-Strand Conformation Polymorphism Based Determination of Two Major Genetic Defects Responsible for a Phenotypic Polymorphism of Cytochrome P450 (CYP) 2C19 in the Japanese Population

By Itoh K.   Inoue K.   Nakao H.   Yanagiwara S.   Tada H.   Suzuki T.  

Analytical Biochemistry, Vol. 284, Iss. 1, 2000-08 ,pp. : 160-162

Elsevier

Access to resources Recommend Favorite

The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19

By Chen Yuan   Liu Hua-fen   Liu Liling   Nguyen Khanh   Jones Elliott B.   Fretland Adrian J.  

Xenobiotica, Vol. 40, Iss. 8, 2010-08 ,pp. : 536-546

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effects of phthalimide derivatives on the activity of the hepatic cytochrome P450 monooxygenases CYP2C9 and CYP2C19

By Kolukisaoglu Üner   Wendler Christian   Goerdes Dirk   Diener Annette   Thurow Kerstin  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 6, 2010-12 ,pp. : 876-886

Informa Healthcare

Access to resources Recommend Favorite

The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPARγ) is associated with risk of coronary artery disease: a meta-analysis

By Wu Zhijun  

Molecular Biology Reports, Vol. 40, Iss. 4, 2013-04 ,pp. : 3101-3112

Springer Publishing Company

Access to resources Recommend Favorite